Meeting News Coverage

<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head id="Head1"><script type="text/javascript" src="/_static/js/bundle-playback.js?v=HxkREWBo" charset="utf-8"></script> <script type="text/javascript" src="/_static/js/wombat.js?v=txqj7nKC" charset="utf-8"></script> <script>window.RufflePlayer=window.RufflePlayer||{};window.RufflePlayer.config={"autoplay":"on","unmuteOverlay":"hidden"};</script> <script type="text/javascript" src="/_static/js/ruffle/ruffle.js"></script> <script type="text/javascript"> __wm.init("https://web.archive.org/web"); __wm.wombat("http://www.healio.com:80/hematology-oncology/meetings/meeting-news-coverage","20130901061442","https://web.archive.org/","web","/_static/", "1378016082"); </script> <link rel="stylesheet" type="text/css" href="/_static/css/banner-styles.css?v=S1zqJCYt" /> <link rel="stylesheet" type="text/css" href="/_static/css/iconochive.css?v=3PDvdIFv" />  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/><title> Meeting News Coverage </title>  <meta name="google-site-verification" content="TCYGZWR7Qscjc3GO_imiutAfXMSCFLpchm8rXzIk-5M"/><meta name="msvalidate.01" content="AB0F11E889D663098DB556BB5ACBB719"/><meta id="metaDescription" name="description"/><meta id="metaKeywords" name="keywords" content="Hematology/Oncology,Bone Marrow Transplantation,Breast Cancer,Cancer Prevention,Gastrointestinal Cancer,Genitourinary Cancer,Geriatric Oncology,Gynecologic Cancer,Head/Neck Cancer,Hematologic Malignancies,Lung Cancer,Melanoma/Skin Cancer,Neuro-Oncology,Palliative Care,Pediatric Hematology,Pediatric Oncology,Practice Management,Prostate Cancer,Sarcoma"/><meta id="Meta1" name="scID"/><meta id="scID" name="scID"/><meta name="robots" content="noindex, nofollow"/> <meta name="PostedDate" content="2012-05-31"/> <meta name="specialties" content="Hematology/Oncology"/> <meta name="specialty" content="Hematology/Oncology"/> <meta name="primary_specialty" content="Hematology/Oncology"/> <meta name="subspecialties" content="Bone Marrow Transplantation,Breast Cancer,Cancer Prevention,Gastrointestinal Cancer,Genitourinary Cancer,Geriatric Oncology,Gynecologic Cancer,Head/Neck Cancer,Hematologic Malignancies,Lung Cancer,Melanoma/Skin Cancer,Neuro-Oncology,Palliative Care,Pediatric Hematology,Pediatric Oncology,Practice Management,Prostate Cancer,Sarcoma"/> <meta name="subspecialty" content="Bone Marrow Transplantation"/> <meta name="subspecialty" content="Breast Cancer"/> <meta name="subspecialty" content="Cancer Prevention"/> <meta name="subspecialty" content="Gastrointestinal Cancer"/> <meta name="subspecialty" content="Genitourinary Cancer"/> <meta name="subspecialty" content="Geriatric Oncology"/> <meta name="subspecialty" content="Gynecologic Cancer"/> <meta name="subspecialty" content="Head/Neck Cancer"/> <meta name="subspecialty" content="Hematologic Malignancies"/> <meta name="subspecialty" content="Lung Cancer"/> <meta name="subspecialty" content="Melanoma/Skin Cancer"/> <meta name="subspecialty" content="Neuro-Oncology"/> <meta name="subspecialty" content="Palliative Care"/> <meta name="subspecialty" content="Pediatric Hematology"/> <meta name="subspecialty" content="Pediatric Oncology"/> <meta name="subspecialty" content="Practice Management"/> <meta name="subspecialty" content="Prostate Cancer"/> <meta name="subspecialty" content="Sarcoma"/> <meta name="content_type" content="Other"/> <meta name="pageid" content="{87A575B2-FB9E-4BFE-945C-E097C55C5F6E}"/> <meta property="og:image" content="https://web.archive.org/web/20130901061442im_/http://213a1ca8842e5e699a80-05ce35571e92a3f7383a191aa5840bba.r66.cf1.rackcdn.com/healio_safe_image.png"/>  <link href="https://web.archive.org/web/20130901061442cs_/http://c341130.r30.cf1.rackcdn.com/styles.css" rel="stylesheet" type="text/css"/>  <link href="https://web.archive.org/web/20130901061442cs_/http://c341130.r30.cf1.rackcdn.com/styles2.css" rel="stylesheet" type="text/css"/><link href="https://web.archive.org/web/20130901061442cs_/http://c341130.r30.cf1.rackcdn.com/tb-ec-lb-min.css" rel="stylesheet" type="text/css" media="screen"/><link href="https://web.archive.org/web/20130901061442cs_/http://0043b493b06d545127da-d7c71b4c9ba1dd44e0cf6fa474e637d7.r99.cf1.rackcdn.com/healiojobs.css" rel="stylesheet" type="text/css"/><link href="https://web.archive.org/web/20130901061442cs_/http://6af4390358a281e0b439-028b17272c3ee5c2953a93a8c54187e2.r22.cf1.rackcdn.com/MediaKits.css" rel="stylesheet" type="text/css"/>   <script src="https://web.archive.org/web/20130901061442js_/http://ajax.googleapis.com/ajax/libs/jquery/1.8.2/jquery.min.js" type="text/javascript"></script> <script src="https://web.archive.org/web/20130901061442js_/http://cdn.jquerytools.org/1.2.7/full/jquery.tools.min.js" type="text/javascript"></script> <script type="text/javascript" language="javascript">$j = $.noConflict();</script> <script src="https://web.archive.org/web/20130901061442js_/http://c341136.r36.cf1.rackcdn.com/easySlider-min.js" type="text/javascript"></script> <script src="https://web.archive.org/web/20130901061442js_/http://c341136.r36.cf1.rackcdn.com/jquery.pager.js" type="text/javascript"></script> <script src="https://web.archive.org/web/20130901061442js_/http://c341136.r36.cf1.rackcdn.com/jquery.jqprint-0.3.js" type="text/javascript"></script> <script src="https://web.archive.org/web/20130901061442js_/http://c341136.r36.cf1.rackcdn.com/thickbox-compressed.js" type="text/javascript"></script> <script src="https://web.archive.org/web/20130901061442js_/http://c341136.r36.cf1.rackcdn.com/jquery.lightbox-0.5.min.js" type="text/javascript"></script> <script src="https://web.archive.org/web/20130901061442js_/http://c341136.r36.cf1.rackcdn.com/swfobject.js" type="text/javascript"></script> <script src="https://web.archive.org/web/20130901061442js_/http://c341136.r36.cf1.rackcdn.com/ecommerce-min.js" type="text/javascript" language="javascript"></script> <script src="https://web.archive.org/web/20130901061442js_/http://c341136.r36.cf1.rackcdn.com/functions-min.js" type="text/javascript" language="javascript"></script> <script src="https://web.archive.org/web/20130901061442js_/http://c341136.r36.cf1.rackcdn.com/checkout-min.js" type="text/javascript"></script> <script src="https://web.archive.org/web/20130901061442js_/http://c341136.r36.cf1.rackcdn.com/jquery.url.min.js" type="text/javascript"></script> <script src="https://web.archive.org/web/20130901061442js_/http://50f7680153f6cba9e65f-a4a4842ad50f9edc1b98e79695b0495a.r26.cf1.rackcdn.com/WaterMark.min.js" type="text/javascript"></script> <script src="https://web.archive.org/web/20130901061442js_/http://50f7680153f6cba9e65f-a4a4842ad50f9edc1b98e79695b0495a.r26.cf1.rackcdn.com/registration.js" type="text/javascript"></script>  <script type="text/javascript"> $(function () { if (window.PIE) { $('#main-content.mtg').each(function () { PIE.attach(this); }); } }); </script> <script type="text/javascript"> var googletag = googletag || {}; googletag.cmd = googletag.cmd || []; (function() { var gads = document.createElement('script'); gads.async = true; gads.type = 'text/javascript'; var useSSL = 'https:' == document.location.protocol; gads.src = (useSSL ? 'https:' : 'http:') + '//web.archive.org/web/20130901061442/http://www.googletagservices.com/tag/js/gpt.js'; var node = document.getElementsByTagName('script')[0]; node.parentNode.insertBefore(gads, node); })(); </script> <script type="text/javascript"> googletag.cmd.push(function() { var slot0 = googletag.defineSlot('/6985521/HematologyOncology_MeetingNewsCoverage_TopLeaderboard', [728, 90], 'div-gpt-ad-1369169134306-4').addService(googletag.pubads()); var slot1 = googletag.defineSlot('/6985521/HematologyOncology_MeetingNewsCoverage_MediumRectangle', [[300, 600], [300, 250]], 'div-gpt-ad-1369169134306-3').addService(googletag.pubads()); googletag.defineSlot('/6985521/HematologyOncology_TextLink1', [1, 1], 'div-gpt-ad-1369169134306-6').addService(googletag.pubads()); googletag.defineSlot('/6985521/HematologyOncology_TextLink2', [1, 1], 'div-gpt-ad-1369169134306-7').addService(googletag.pubads()); var slot2 = googletag.defineSlot('/6985521/HematologyOncology_RunOfSpecialty_MarketingRectangle1', [300, 100], 'div-gpt-ad-1369169134306-1').addService(googletag.pubads()); var slot3 = googletag.defineSlot('/6985521/HematologyOncology_RunOfSpecialty_MarketingRectangle2', [300, 100], 'div-gpt-ad-1369169134306-2').addService(googletag.pubads()); var slot4 = googletag.defineSlot('/6985521/HematologyOncology_MeetingNewsCoverage_BottomLeaderboard', [728, 90], 'div-gpt-ad-1369169134306-0').addService(googletag.pubads()); var slot5 = googletag.defineSlot('/6985521/HematologyOncology_RunofSpecialty_Interstitial', [300, 250], 'div-gpt-ad-1369169134306-5').addService(googletag.pubads()); googletag.pubads().setTargeting("Verification Status", "False"); googletag.pubads().enableSingleRequest(); googletag.enableServices(); setInterval(function(){googletag.pubads().refresh([slot0]);}, 120000); setInterval(function(){googletag.pubads().refresh([slot1]);}, 120000); setInterval(function(){googletag.pubads().refresh([slot2]);}, 120000); setInterval(function(){googletag.pubads().refresh([slot3]);}, 120000); setInterval(function(){googletag.pubads().refresh([slot4]);}, 120000); setInterval(function(){googletag.pubads().refresh([slot5]);}, 120000); }); </script> <link rel="shortcut icon" type="image/x-icon" href="https://web.archive.org/web/20130901061442im_/http://213a1ca8842e5e699a80-05ce35571e92a3f7383a191aa5840bba.r66.cf1.rackcdn.com/favicon.ico"/> <style type="text/css"> #wrap:before, #wrap:after { content: " "; display: table; } #wrap:after { clear: both; } </style> <script type="text/javascript">var NREUMQ=NREUMQ||[];NREUMQ.push(["mark","firstbyte",new Date().getTime()]);</script></head> <body id="Body"> <form method="post" action="/web/20130901061442/http://www.healio.com/hematology-oncology/meetings/meeting-news-coverage" id="frmMain"> <div class="aspNetHidden"> <input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="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"/> </div> <script src="/web/20130901061442js_/http://www.healio.com/ScriptResource.axd?d=hA-Ei1IJPg5QmnYHbOyE3JxWi87NCFswS44W1r0AKu-NhvyhdHKDJiG1w3h0tM0aYoGAiKv8wjFdkD8mFdZSzyJN3OF5LS-ymJWsYUNDw6zkKu2iAWAMZOx93s7xQkv1IQ0hNSzeCl32wd0QVUtQDjn_rWI8Rmik1P1gq6gUSe41&t=ffffffff940d030f" type="text/javascript"></script> <div id="fb-root"> </div>  <div id="wrap">  <div id="header">  <div class="col1">  <div class="leaderboard">  <div id="div-gpt-ad-1369169134306-4"> <script type="text/javascript"> googletag.cmd.push(function() { googletag.display('div-gpt-ad-1369169134306-4'); }); </script> </div> </div>  <p class="survey">  <a href="https://web.archive.org/web/20130901061442/http://healio.wufoo.com/forms/z7x3x5/" onclick="window.open(this.href, null, 'height=768, width=680, toolbar=0, location=0, status=1, scrollbars=1, resizable=1'); return false" rel="nofollow"> Tell us</a> what you think about Healio</p> <ul id="ulTopNav" class="utility-nav"> <li class="nw"><a href="https://web.archive.org/web/20130901061442/http://www.healio.com/footer/account-information/create-new-user?ReturnUrl=%2f">News Wire Alerts</a></li> <li class="rss"><a href="https://web.archive.org/web/20130901061442/http://www.healio.com/rss">RSS Feeds</a></li> </ul>  <ul id="brand"> <li class="specialty-link-healio"> <h1 class="specialty-healio"><a href="/web/20130901061442/http://www.healio.com/">Healio</a></h1> <h1 class="specialty-sub"><a href="/web/20130901061442/http://www.healio.com/hematology-oncology">Hematology/Oncology</a></h1> </li> <li class="logo"> <a href="/web/20130901061442/http://www.healio.com/hematology oncology"> <img alt="" height="60" width="372" src="/web/20130901061442im_/http://www.healio.com/hematology-oncology/meetings/~/media/DCE448D003864B5783890EE8BC76D972.ashx"/> </a> </li> </ul>  </div>   <div class="col2" id="greetingcontainer"> <script type="text/javascript"> $j(document).ready(function () {$j("#greeting").load("/Presentation/Layouts/Healio/Greeting.aspx",{'returnurl':'/hematology-oncology/meetings/meeting-news-coverage'}); }); </script> <div id="greeting"> <h4 class="pc-bar">Loading...</h4> <ul class="content"> <li class="update"> <p> <a href="/web/20130901061442/http://www.healio.com/footer/account-information/login.aspx"><strong>Sign in for a personal experience.</strong></a></p> <p> Customized content served to meet your interests. </p> </li> </ul>  </div>   <script type="text/javascript"> $j(document).ready(function () { var value1 = $j('input:radio[name=scope]:checked').val(); var value2 = ""; $j("#q").keyup(function (event) { if (event.keyCode == 13 && $j(this).val() != "") { $j("#btnG").click(); } }); $j("input:radio[name=scope]").click(function () { value1 = $j(this).val(); //alert(value1); }); $j("#btnG").click(function () { var u = searchRoot + "/search?q=" + $j("#q").val() + ((typeof (value1) === 'undefined' || value1 =="") ? "" : "&" + value1); window.location.replace(u); }); $j("#q").focus(function () { $j("#q").css('background', 'none') }); }); </script> <script language="javascript">var searchRoot='/hematology-oncology';</script> <div id="search"> <input type="text" id="q" name="q"/> <input type="button" class="submit" name="btnG" id="btnG" value="Search"/> <script src="https://web.archive.org/web/20130901061442js_/http://www.google.com/coop/cse/brand?form=cse-search-box&lang=en" type="text/javascript"></script>  <ul id="greetingContainer_ctl01_Refiner" class="form-controls"> <li> <input type="radio" name="scope" value=""/>All Specialties</li> <li>  <input type="radio" name="scope" value="requiredfields=specialty:Hematology/Oncology" checked="checked"/>Hematology/Oncology</li> </ul>  </div>  </div>  </div>   <div id="menu">   <ul id="subspecialty-menu-b"> <li class="first"><a class="collapsed" style="display:none;">Subspecialties</a> <ul> <li><a href="/web/20130901061442/http://www.healio.com/hematology-oncology" id="menu_0_anchorAll">All Hematology/Oncology</a></li> <li><a class="resource" href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013"> Highlights from ASCO 2013</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/bone-marrow-transplantation"> Bone Marrow Transplantation</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/breast-cancer"> Breast Cancer</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/cancer-prevention"> Cancer Prevention</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/gastrointestinal-cancer"> Gastrointestinal Cancer</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/genitourinary-cancer"> Genitourinary Cancer</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/geriatric-oncology"> Geriatric Oncology</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/gynecologic-cancer"> Gynecologic Cancer</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/head-neck-cancer"> Head/Neck Cancer</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/hematologic-malignancies"> Hematologic Malignancies</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/hematology"> Hematology</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/lung-cancer"> Lung Cancer</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/melanoma-skin-cancer"> Melanoma/Skin Cancer</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/neuro-oncology"> Neuro-Oncology</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/palliative-care"> Palliative Care</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/pediatric-oncology"> Pediatric Oncology</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/practice-management"> Practice Management</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/prostate-cancer"> Prostate Cancer</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/sarcoma"> Sarcoma</a></li> <li><a class="resource" href="/web/20130901061442/http://www.healio.com/hematology-oncology/hemonc-today-melanoma"> Highlights from HemOnc Today Melanoma 2013</a></li> </ul> </li> </ul> <ul id="specialty-menu-a"> <li> <h5 class="menu-head"> <a href="/web/20130901061442/http://www.healio.com/">All Specialties</a> </h5> </li> <li><a class="" href="/web/20130901061442/http://www.healio.com/adolescent-medicine"> Adolescent Medicine</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/allergy-immunology"> Allergy/Immunology</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/cardiology"> Cardiology</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/dermatology"> Dermatology</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/endocrinology"> Endocrinology</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/gastroenterology"> Gastroenterology</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/geriatric-medicine"> Geriatric Medicine</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/health-professions"> Health Professions</a></li> <li><a class="active" href="/web/20130901061442/http://www.healio.com/hematology-oncology"> Hematology/Oncology</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/hepatology"> Hepatology</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/infectious-disease"> Infectious Disease</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/nursing/journals"> Nursing</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/ophthalmology"> Ophthalmology</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/optometry"> Optometry</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/orthopedics"> Orthopedics</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/orthotics-prosthetics"> Orthotics/Prosthetics</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/pediatrics"> Pediatrics</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/psychiatry"> Psychiatry</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/rheumatology"> Rheumatology</a></li> <li><a class="" href="/web/20130901061442/http://www.healio.com/sports-medicine"> Sports Medicine</a></li> </ul> <div id="awardgroup"> <ul class="award-wrap"> <li class="col1"><a href="https://web.archive.org/web/20130901061442/http://www.healio.com/hematology-oncology/practice-management/news/online/%7Bbaa1a66a-8c99-4530-b5b2-4bd5946fd8c9%7D/healiocom-wins-2012-best-publishing-site-award" rel="nofollow">Sitecore Site of the Year</a></li> <li class="col2"><a href="https://web.archive.org/web/20130901061442/http://www.healio.com/news/online/%7B58FDC6A6-27D7-4AD3-8D3E-ED63D35F8BE2%7D/Healiocom-named-Medical-Marketing--Media-2013-award-finalist" rel="nofollow">Finalist - MMM Awards 2013</a></li> <li class="col3"><a href="https://web.archive.org/web/20130901061442/http://www.healio.com/news/online/%7BC15DEDA5-C675-417E-B896-80686B2C137C%7D/Healiocom-wins-2013-APEX-Grand-Award" rel="nofollow">Healio.com wins 2013 APEX Grand Award</a></li> </ul> </div> </div>   <div id="content-wrap">  <ul class="nav"> <li><a href="/web/20130901061442/http://www.healio.com/hematology-oncology/news" title="News" target=""> News</a> <ul class="sub_menu"> <li class="first"> <a class="all" href="/web/20130901061442/http://www.healio.com/hematology-oncology/news" title="News" target=""> All News</a> </li> <li class="first"> <a class="all" href="#" title="News" target=""> News Publications</a> </li> <li class=""> <a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/news/print/hematology-oncology" title="News" target=""> HemOnc Today</a> </li> <li class=""> <a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/news/publication-exclusives" title="News" target=""> Publication Exclusives</a> </li> <li class="first"> <a class="all" href="/web/20130901061442/http://www.healio.com/hematology-oncology/news/meeting-news-coverage" title="News" target=""> Meeting News Coverage</a> </li> </ul> </li> <li><a href="https://web.archive.org/web/20130901061442/http://video.healio.com/pages/hematology-oncology" title="Video" target=""> Video</a> <ul class="sub_menu"> </ul> </li> <li><a href="/web/20130901061442/http://www.healio.com/hematology-oncology/blogs" title="Blogs" target=""> Blogs</a> <ul class="sub_menu"> <li class="first"> <a class="all" href="/web/20130901061442/http://www.healio.com/hematology-oncology/blogs" title="News" target=""> All Blogs</a> </li> <li class=""> <a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/blogs/adam-brufsky" title="News" target=""> Adam Brufsky</a> </li> <li class=""> <a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/blogs/william-wood" title="News" target=""> William Wood</a> </li> </ul> </li> <li><a href="/web/20130901061442/http://www.healio.com/hematology-oncology/education-lab" title="Education Lab/CME" target=""> Education Lab/CME</a> <ul class="sub_menu"> <li class="first"> <a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/education-lab" title="News" target=""> Education Lab Home</a> </li> <li class=""> <a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/education-lab?selection=0" title="News" target=""> CME</a> </li> </ul> </li> <li><a href="/web/20130901061442/http://www.healio.com/hematology-oncology/books" title="Books" target=""> Books</a> <ul class="sub_menu"> </ul> </li> <li><a href="/web/20130901061442/http://www.healio.com/hematology-oncology/meetings" title="Meetings" target=""> Meetings</a> <ul class="sub_menu"> <li class="first"> <a class="all" href="/web/20130901061442/http://www.healio.com/hematology-oncology/meetings" title="News" target=""> Meetings/Courses</a> </li> <li class="first"> <a class="all" href="#" title="News" target=""> Featured Meetings</a> </li> <li class=""> <a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/meetings/{CE539264-97E8-4B56-997D-26765B00D337}/Breast-Cancer-Symposium" title="News" target=""> Breast Cancer Symposium</a> </li> <li class=""> <a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/meetings/{D3FBDD76-62F6-4ABA-AF62-7B3680F47F6B}/European-Cancer-Congress" title="News" target=""> European Cancer Congress</a> </li> <li class=""> <a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/meetings/{A9595728-52D6-431A-84EE-3EC593ECEC84}/American-Society-of-Hematology-Annual-Meeting-and-Exposition" title="News" target=""> American Society of Hematology Annual Meeting and Exposition</a> </li> <li class=""> <a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/meetings/{1708ADCB-F7C6-4158-9800-90DEFC5DFA7C}/San-Antonio-Breast-Cancer-Symposium" title="News" target=""> San Antonio Breast Cancer Symposium</a> </li> <li class=""> <a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/meetings/{638BEC32-EDCB-4DBD-895A-163CE803DCA8}/Gastrointestinal-Cancers-Symposium" title="News" target=""> Gastrointestinal Cancers Symposium</a> </li> <li class=""> <a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/meetings/{34A89187-A814-451A-9F3F-A0C16B31F14B}/Genitourinary-Cancers-Symposium" title="News" target=""> Genitourinary Cancers Symposium</a> </li> <li class=""> <a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/meetings/{CCE16114-B084-4EE8-B50E-556984879D69}/HemOnc-Today-Melanoma-and-Cutaneous-Malignancies---" title="News" target=""> HemOnc Today Melanoma</a> </li> <li class=""> <a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/meetings/{F18EF617-384C-4DA9-B5FD-B9E80A007657}/ASCO-Annual-Meeting" title="News" target=""> ASCO Annual Meeting</a> </li> <li class=""> <a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/meetings/{537DCC12-EBCF-4032-AFE1-A832198C803F}/European-Society-for-Medical-Oncology-Annual-Congress" title="News" target=""> European Society for Medical Oncology Annual Congress</a> </li> <li class=""> <a class="" href="/web/20130901061442/http://www.healio.com/hematology-oncology/meetings/{EAD2EF73-A0D2-4EED-96B1-5021A03E8306}/San-Antonio-Breast-Cancer-Symposium" title="News" target=""> San Antonio Breast Cancer Symposium</a> </li> <li class="first"> <a class="all" href="/web/20130901061442/http://www.healio.com/hematology-oncology/meetings/meeting-news-coverage" title="News" target=""> Meeting News Coverage</a> </li> </ul> </li> <li><a href="/web/20130901061442/http://www.healio.com/hematology-oncology/careers" title="Careers" target=""> Careers</a> <ul class="sub_menu"> </ul> </li> </ul> <script type="text/javascript"> jQuery(".nav>li:last>a").addClass("last"); //fix for IE last-child style </script>   <div id="main-content">  <p id="breadcrumbs"> <a href="/web/20130901061442/http://www.healio.com/"> Healio</a> <span>›</span> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology"> Hematology/Oncology</a> <span>›</span> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/meetings"> Meetings</a> <span>›</span> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/meetings/meeting-news-coverage"> Meeting News Coverage</a> </p>  <script type="text/javascript"> $(document).ready(function () { // hides the slickbox as soon as the DOM is ready (a little sooner than page load) $('#slickbox').hide(); // slides down, up, and toggle the slickbox on click $('#slick-down').click(function () { $('#slickbox').slideDown('slow'); return false; }); $('#slick-up').click(function () { $('#slickbox').slideUp('fast'); return false; }); $('#slick-slidetoggle').click(function () { $('#slickbox').slideToggle(400); $(this).text($(this).text() == 'See All 禄' ? 'Collapse' : 'See All 禄'); return false; }); }); </script>  <div class="lead-story-alt"> <h2> <a id="layout_0_phmaincontent_1_hlArticleTitle" href="/web/20130901061442/http://www.healio.com/hematology-oncology/melanoma-skin-cancer/news/print/hematology-oncology/{1DD3F7B6-34A1-42E6-80E2-4086C35ABCEE}/Oncolytic-immunotherapy-improved-durable-response-survival-in-metastatic-melanoma">Oncolytic immunotherapy improved durable response, survival in metastatic melanoma</a> </h2> <ul class="meta-info"> <li>HemOnc Today, August 10, 2013</li> </ul>   <p> <p class="BodyCxSpFirst">CHICAGO — Talimogene laherparepvec demonstrated a statistically significant improvement in durable response rate compared with granulocyte-macrophage colony-stimulating factor among patients with unresected stage IIIB/C and IV melanoma, according to results of a phase 3 study presented at the ASCO Annual Meeting.</p> <p class="BodyCxSpMiddle">An interim analysis also showed a trend toward improved OS with talimogene laherparepvec (HR=0.79; 95% CI, 0.61-1.02).</p><a id="layout_0_phmaincontent_1_hlMore" class="jump-link" href="/web/20130901061442/http://www.healio.com/hematology-oncology/melanoma-skin-cancer/news/print/hematology-oncology/{1DD3F7B6-34A1-42E6-80E2-4086C35ABCEE}/Oncolytic-immunotherapy-improved-durable-response-survival-in-metastatic-melanoma">More <span>»</span></a> </p> </div>  <h4 class="section-head">Additional headlines from 2013 ASCO Annual Meeting</h4>  <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/prostate-cancer/news/online/{BE14C148-5EBE-4682-B1F8-D4FEFBB3FC51}/Enzalutamide-exhibited-high-PSA-response-rate-similar-efficacy-to-castration"> Enzalutamide exhibited high PSA response rate, similar efficacy to castration </a></h4> </li> <li class="meta-info"> July 2, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/prostate-cancer/news/print/hematology-oncology/{C25DAA50-EF00-409D-B1C4-B0C234CBBBD2}/Enzalutamide-exhibited-high-PSA-response-rate-similar-efficacy-to-castration"> Enzalutamide exhibited high PSA response rate, similar efficacy to castration </a></h4> </li> <li class="meta-info"> HemOnc Today, July 25, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="video-flag">Video</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/calcium-magnesium-ineffective-in-preventing-or-decreasing-neuropathy-in-colorectal-cancer"> Calcium, magnesium ineffective at preventing or decreasing neuropathy in colorectal cancer</a></h4> </li> <li class="meta-info"> June 26, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="video-flag">Video</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/cetuximab-shows-promise-for-pfs-in-colorectal-cancer"> Studies offer insights into role of cetuximab in colorectal cancer treatment</a></h4> </li> <li class="meta-info"> June 26, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/cetuximab-plus-folfiri-extended-survival-in-metastatic-colorectal-cancer"> Cetuximab plus FOLFIRI extended survival in metastatic colorectal cancer</a></h4> </li> <li class="meta-info"> June 25, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/gastrointestinal-cancer/news/print/hematology-oncology/{9668D0CC-A5E0-4011-A8B5-E001ECA72059}/Cetuximab-plus-FOLFIRI-extended-survival-in-metastatic-colorectal-cancer"> Cetuximab plus FOLFIRI extended survival in metastatic colorectal cancer</a></h4> </li> <li class="meta-info"> HemOnc Today, July 10, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="video-flag">Video</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/no-benefit-reported-in-colorectal-monitoring-with-both-ct-and-carcinoembryonic-antigen-testing"> No benefit reported in colorectal monitoring with both CT and carcinoembryonic antigen testing</a></h4> </li> <li class="meta-info"> June 25, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/nab-paclitaxel-plus-gemcitabine-may-be-new-standard-for-metastatic-pancreatic-cancer"> Nab-paclitaxel plus gemcitabine may be new standard for metastatic pancreatic cancer</a></h4> </li> <li class="meta-info"> June 21, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/gastrointestinal-cancer/news/print/hematology-oncology/{E800A6C3-4CB6-4707-8628-0C1B87999836}/Nab-paclitaxel-plus-gemcitabine-may-be-new-standard-for-metastatic-pancreatic-cancer"> Nab-paclitaxel plus gemcitabine may be new standard for metastatic pancreatic cancer</a></h4> </li> <li class="meta-info"> HemOnc Today, July 25, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="video-flag">Video</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/e1308-reported-encouraging-overall-response-rates-with-decreased-toxicity"> E1308 reported encouraging overall response rates with decreased toxicity</a></h4> </li> <li class="meta-info"> June 19, 2013</li> </ul> <div id="slickbox"> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="video-flag">Video</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/ziv-aflibercept-associated-with-promising-results-for-the-treatment-of-metastatic-colorectal-cancer"> Ziv-aflibercept associated with promising results for the treatment of metastatic colorectal cancer</a></h4> </li> <li class="meta-info"> June 19, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="video-flag">Video</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/hpv-p16-presence-linked-to-significant-improvements-in-response-os-in-recurrent-metastatic-scchn"> HPV, p16 presence linked to significant improvements in response, OS in recurrent, metastatic SCCHN</a></h4> </li> <li class="meta-info"> June 18, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="video-flag">Video</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/addition-of-lapatnib-linked-to-improved-response-not-survival-outcomes-in-gastric-cancer"> Addition of lapatnib linked to improved response, not survival outcomes in gastric cancer</a></h4> </li> <li class="meta-info"> June 18, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="video-flag">Video</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/t-vec-yielded-encouraging-response-rates-and-survival-outcomes-in-unresected-melanoma"> T-VEC yielded encouraging response rates and survival outcomes in unresected melanoma</a></h4> </li> <li class="meta-info"> June 17, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/gene-mutations-common-in-black-women-at-high-risk-for-breast-cancer"> Gene mutations common in black women at high risk for breast cancer</a></h4> </li> <li class="meta-info"> June 14, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/breast-cancer/news/print/hematology-oncology/{0AB126E3-5AD6-4F5F-BB99-762E984D7752}/Gene-mutations-common-in-black-women-at-high-risk-for-breast-cancer"> Gene mutations common in black women at high risk for breast cancer</a></h4> </li> <li class="meta-info"> HemOnc Today, July 10, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/addition-of-ganetespib-to-docetaxel-improved-response-survival-in-lung-adenocarcinoma"> Addition of ganetespib to docetaxel improved response, survival in lung adenocarcinoma</a></h4> </li> <li class="meta-info"> June 13, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/lung-cancer/news/print/hematology-oncology/{ABB184AF-E5DA-4909-A60F-44E574C9F48B}/Addition-of-ganetespib-to-docetaxel-improved-response-survival-in-lung-adenocarcinoma"> Addition of ganetespib to docetaxel improved response, survival in lung adenocarcinoma</a></h4> </li> <li class="meta-info"> HemOnc Today, July 25, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/weekly-paclitaxel-produced-fewer-toxicities-than-biweekly-schedule"> Weekly paclitaxel produced fewer toxicities than biweekly schedule</a></h4> </li> <li class="meta-info"> June 13, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/breast-cancer/news/print/hematology-oncology/{34F4CD36-760C-4852-AD35-3F507DC50E27}/Weekly-paclitaxel-produced-fewer-toxicities-than-biweekly-schedule"> Weekly paclitaxel produced fewer toxicities than biweekly schedule</a></h4> </li> <li class="meta-info"> HemOnc Today, July 25, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="video-flag">Video</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/recurrent-themes-of-asco-money-and-molecules"> Recurrent themes of ASCO: Money and molecules</a></h4> </li> <li class="meta-info"> June 7, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/obinutuzumab-rituximab-improved-chlorambucil-efficacy-in-cll"> Obinutuzumab, rituximab improved chlorambucil efficacy in CLL</a></h4> </li> <li class="meta-info"> June 7, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/hematologic-malignancies/news/print/hematology-oncology/{7502D91A-4E41-4620-8708-012F9732CD0B}/Obinutuzumab-rituximab-improved-chlorambucil-efficacy-in-CLL"> Obinutuzumab, rituximab improved chlorambucil efficacy in CLL</a></h4> </li> <li class="meta-info"> HemOnc Today, July 25, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="video-flag">Video</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/elderly-patients-with-cll-benefit-from-combination-therapies-vs-chlorambucil-alone"> Elderly patients with CLL benefit from combination therapies vs. chlorambucil alone</a></h4> </li> <li class="meta-info"> June 7, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/radiotherapy-showed-similar-control-rates-fewer-side-effects-than-dissection"> Radiotherapy showed similar control rates, fewer side effects than dissection</a></h4> </li> <li class="meta-info"> June 6, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/breast-cancer/news/print/hematology-oncology/{27101478-6325-4BC7-B0E3-B5E9803CD372}/Radiotherapy-showed-similar-control-rates-fewer-side-effects-than-dissection"> Radiotherapy showed similar control rates, fewer side effects than dissection</a></h4> </li> <li class="meta-info"> HemOnc Today, July 25, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/idelalisib-plus-rituximab-shows-promise-as-frontline-therapy-for-cll"> Idelalisib plus rituximab shows promise as frontline therapy for CLL</a></h4> </li> <li class="meta-info"> June 6, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/hematologic-malignancies/news/print/hematology-oncology/{99D5DCDC-BCB2-448B-8825-FB2B79281151}/Idelalisib-plus-rituximab-shows-promise-as-frontline-therapy-for-CLL"> Idelalisib plus rituximab shows promise as frontline therapy for CLL</a></h4> </li> <li class="meta-info"> HemOnc Today, July 10, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/selumetinib-increased-pfs-reduced-tumor-size-in-uveal-melanoma"> Selumetinib increased PFS, reduced tumor size in uveal melanoma</a></h4> </li> <li class="meta-info"> June 6, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/melanoma-skin-cancer/news/print/hematology-oncology/{DB3975D1-A7B3-4DF7-9CD9-4265FAF7C089}/Selumetinib-increased-PFS-reduced-tumor-size-in-uveal-melanoma"> Selumetinib increased PFS, reduced tumor size in uveal melanoma</a></h4> </li> <li class="meta-info"> HemOnc Today, July 25, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/bevacizumab-did-not-increase-os-in-glioblastoma"> Bevacizumab did not increase OS in glioblastoma </a></h4> </li> <li class="meta-info"> June 5, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/neuro-oncology/news/print/hematology-oncology/{66D85C0D-23BD-4B00-B435-9F5D2E8100D5}/Bevacizumab-did-not-increase-OS-in-glioblastoma"> Bevacizumab did not increase OS in glioblastoma </a></h4> </li> <li class="meta-info"> HemOnc Today, July 25, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/addition-of-bevacizumab-to-temozolomide-radiation-improved-outcomes-in-glioblastoma"> Addition of bevacizumab to temozolomide, radiation improved outcomes in glioblastoma</a></h4> </li> <li class="meta-info"> June 5, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/neuro-oncology/news/print/hematology-oncology/{464D676E-570E-4A13-A4EF-CA1685873169}/Addition-of-bevacizumab-to-temozolomide-radiation-improved-outcomes-in-glioblastoma"> Addition of bevacizumab to temozolomide, radiation improved outcomes in glioblastoma</a></h4> </li> <li class="meta-info"> HemOnc Today, July 25, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/hpv-p16-expression-associated-with-significant-improvement-in-response-os-in-metastatic-scchn"> HPV, p16 expression associated with significant improvement in response, OS in recurrent, metastatic SCCHN </a></h4> </li> <li class="meta-info"> June 5, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/head-neck-cancer/news/print/hematology-oncology/{C35DC763-8081-4990-8D1B-3A3489C27719}/HPV-p16-expression-associated-with-significant-improvement-in-response-OS-in-recurrent-metastatic-SCCHN"> HPV, p16 expression associated with significant improvement in response, OS in recurrent, metastatic SCCHN </a></h4> </li> <li class="meta-info"> HemOnc Today, June 25, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/statin-aspirin-use-linked-to-decreased-mortality-in-uterine-cancer"> Statin, aspirin use linked to decreased mortality in uterine cancer</a></h4> </li> <li class="meta-info"> June 5, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/gynecologic-cancer/news/print/hematology-oncology/{F15DEE77-031D-4465-86E3-BF337D80C66A}/Statin-aspirin-use-linked-to-decreased-mortality-in-uterine-cancer"> Statin, aspirin use linked to decreased mortality in uterine cancer</a></h4> </li> <li class="meta-info"> HemOnc Today, June 25, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="video-flag">Video</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/focus-on-kinase-inhibitors-limited-efficacy-of-surveillance-among-significant-developments"> Focus on kinase inhibitors, limited efficacy of surveillance among significant developments at lymphoma sessions</a></h4> </li> <li class="meta-info"> June 4, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/novel-alk-tki-shows-promise-in-nsclc"> Novel ALK TKI shows promise in NSCLC</a></h4> </li> <li class="meta-info"> June 4, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/lung-cancer/news/print/hematology-oncology/{D359B0C7-7A53-4F4E-A0B9-3DFDD489EE9D}/Novel-ALK-TKI-shows-promise-in-NSCLC"> Novel ALK TKI shows promise in NSCLC</a></h4> </li> <li class="meta-info"> HemOnc Today, June 25, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="video-flag">Video</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/symptoms-not-surveillance-as-effective-at-detection-of-relapse-in-some-cancers"> Symptoms as effective as surveillance for detection of relapse in some cancers</a></h4> </li> <li class="meta-info"> June 4, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/bevacizumab-plus-chemotherapy-prolonged-os-pfs-in-cervical-cancer"> Bevacizumab plus chemotherapy prolonged OS, PFS in cervical cancer</a></h4> </li> <li class="meta-info"> June 4, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/gynecologic-cancer/news/print/hematology-oncology/{EFAED41A-C0AD-4554-A66F-5E452F420F8E}/Bevacizumab-plus-chemotherapy-prolonged-OS-PFS-in-cervical-cancer"> Bevacizumab plus chemotherapy prolonged OS, PFS in cervical cancer</a></h4> </li> <li class="meta-info"> HemOnc Today, July 25, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="video-flag">Video</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/attom-extended-hormonal-therapy-should-be-considered-for-higher-risk-patients"> aTTom: Extended hormonal therapy should be considered for higher risk patients</a></h4> </li> <li class="meta-info"> June 4, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/routine-surveillance-imaging-provided-no-survival-benefit-in-hl"> Routine surveillance imaging provided no survival benefit in HL</a></h4> </li> <li class="meta-info"> June 4, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/hematologic-malignancies/news/print/hematology-oncology/{38D535A3-A772-4D2D-B023-8B0B52B22478}/Routine-surveillance-imaging-provided-no-survival-benefit-in-HL"> Routine surveillance imaging provided no survival benefit in HL</a></h4> </li> <li class="meta-info"> HemOnc Today, July 10, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="video-flag">Video</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/atlas-outcomes-confirmed-10-years-is-superior-to-5-years-of-tamoxifen-in-prevention-of-breast-cancer"> ATLAS outcomes confirmed: 10 years of tamoxifen superior to 5 years for prevention of breast cancer recurrence</a></h4> </li> <li class="meta-info"> June 3, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/extended-tamoxifen-reduced-breast-cancer-recurrence-mortality"> Extended tamoxifen reduced breast cancer recurrence, mortality</a></h4> </li> <li class="meta-info"> June 3, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/breast-cancer/news/print/hematology-oncology/{B845F480-9DD5-4F72-90DC-F3491BCA418D}/Extended-tamoxifen-reduced-breast-cancer-recurrence-mortality"> Extended tamoxifen reduced breast cancer recurrence, mortality</a></h4> </li> <li class="meta-info"> HemOnc Today, July 10, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/vinegar-screening-technique-reduced-cervical-cancer-mortality-by-31-percent-in-india"> Vinegar screening technique reduced cervical cancer mortality by 31% in India </a></h4> </li> <li class="meta-info"> June 3, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/gynecologic-cancer/news/print/hematology-oncology/{51F39579-8E5D-4669-8303-EDA05C88C182}/Vinegar-screening-technique-reduced-cervical-cancer-mortality-by-31-in-India"> Vinegar screening technique reduced cervical cancer mortality by 31% in India </a></h4> </li> <li class="meta-info"> HemOnc Today, July 10, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/induction-chemotherapy-followed-by-low-dose-radiation-cetuximab-appears-safe-effective-in-hpv-opscc"> Induction chemotherapy followed by low-dose radiation/cetuximab appears safe, effective in HPV-associated OPSCC</a></h4> </li> <li class="meta-info"> June 3, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/head-neck-cancer/news/print/hematology-oncology/{98A4E58A-18A5-4E92-B9B0-7F9713355668}/Induction-chemotherapy-followed-by-low-dose-radiationcetuximab-appears-safe-effective-in-HPV-associated-OPSCC"> Induction chemotherapy followed by low-dose radiation/cetuximab appears safe, effective in HPV-associated OPSCC</a></h4> </li> <li class="meta-info"> HemOnc Today, July 25, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="video-flag">Video</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/axillary-dissection-alone-radiation-alone-both-viable-treatments-in-patients-with-sentinel-nodes"> Axillary dissection alone, radiation alone, both viable treatments in patients with positive sentinel nodes</a></h4> </li> <li class="meta-info"> June 3, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/nintedanib-associated-with-comparable-effectiveness-fewer-adverse-events-than-sunitinib-in-rcc"> Nintedanib associated with comparable effectiveness, fewer adverse events than sunitinib in RCC</a></h4> </li> <li class="meta-info"> June 3, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/genitourinary-cancer/news/print/hematology-oncology/{0C8CA688-D3DB-4037-AFE1-82DB2C9AE30F}/Nintedanib-associated-with-comparable-effectiveness-fewer-adverse-events-than-sunitinib-in-RCC"> Nintedanib associated with comparable effectiveness, fewer adverse events than sunitinib in RCC</a></h4> </li> <li class="meta-info"> HemOnc Today, June 25, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="video-flag">Video</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/screening-with-acetic-acid-reduced-deaths-from-cervical-cancer-in-study-of-indian-women"> Screening with acetic acid reduced deaths from cervical cancer in India</a></h4> </li> <li class="meta-info"> June 3, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/sorafenib-slowed-disease-progression-in-metastatic-differentiated-thyroid-cancer"> Sorafenib slowed disease progression in metastatic differentiated thyroid cancer </a></h4> </li> <li class="meta-info"> June 3, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/head-neck-cancer/news/print/hematology-oncology/{F7E45B9A-DE18-45E4-AA56-70C942E101BE}/Sorafenib-slowed-disease-progression-in-metastatic-differentiated-thyroid-cancer"> Sorafenib slowed disease progression in metastatic differentiated thyroid cancer </a></h4> </li> <li class="meta-info"> HemOnc Today, July 25, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="video-flag">Video</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/decision-sorafenib-shown-to-prolong-pfs-in-patients-with-metastatic-thyroid-cancer"> DECISION: Sorafenib shown to prolong PFS in patients with metastatic thyroid cancer</a></h4> </li> <li class="meta-info"> June 2, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/pten-loss-pik3ca-mutation-predicted-resistance-to-cetuximab-in-hnscc"> PTEN loss, PIK3CA mutation predicted resistance to cetuximab in HNSCC</a></h4> </li> <li class="meta-info"> June 2, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/head-neck-cancer/news/print/hematology-oncology/{0E111EFC-C62F-4501-B9F2-78D1E451F01E}/PTEN-loss-PIK3CA-mutation-predicted-resistance-to-cetuximab-in-HNSCC"> PTEN loss, PIK3CA mutation predicted resistance to cetuximab in HNSCC</a></h4> </li> <li class="meta-info"> HemOnc Today, July 10, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/spouses-of-patients-with-hpv-associated-oropharyngeal-cancer-not-at-increased-risk"> Spouses of patients with HPV-associated oropharyngeal cancer not at increased risk</a></h4> </li> <li class="meta-info"> June 2, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/head-neck-cancer/news/print/hematology-oncology/{78319EE2-1199-46F3-96DC-CB4785B41B34}/Spouses-of-patients-with-HPV-associated-oropharyngeal-cancer-not-at-increased-risk"> Spouses of patients with HPV-associated oropharyngeal cancer not at increased risk</a></h4> </li> <li class="meta-info"> HemOnc Today, June 25, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="video-flag">Video</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/fire-3-superior-os-observed-in-folfiri-plus-cetuximab-in-patients-with-metastatic-colon-cancer"> FIRE-3: Superior OS observed in FOLFIRI plus cetuximab in patients with metastatic colon cancer</a></h4> </li> <li class="meta-info"> June 2, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/nivolumab-induced-long-lasting-response-in-stage-iv-melanoma"> Nivolumab induced long-lasting response in stage IV melanoma</a></h4> </li> <li class="meta-info"> June 1, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/melanoma-skin-cancer/news/print/hematology-oncology/{189A59BB-12CA-4CF7-816E-C72564454CB2}/Nivolumab-induced-long-lasting-response-in-stage-IV-melanoma"> Nivolumab induced long-lasting response in stage IV melanoma</a></h4> </li> <li class="meta-info"> HemOnc Today, June 25, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/gm-csf-plus-ipilimumab-extended-os-in-metastatic-melanoma"> GM-CSF plus ipilimumab extended OS in metastatic melanoma</a></h4> </li> <li class="meta-info"> June 1, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/melanoma-skin-cancer/news/print/hematology-oncology/{1000DEAA-EF8C-4063-8264-D25FE2D842FE}/GM-CSF-plus-ipilimumab-extended-OS-in-metastatic-melanoma"> GM-CSF plus ipilimumab extended OS in metastatic melanoma</a></h4> </li> <li class="meta-info"> HemOnc Today, July 10, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/maintenance-pazopanib-extends-dfs-in-women-with-advanced-ovarian-cancer"> Maintenance pazopanib extends DFS in women with advanced ovarian cancer</a></h4> </li> <li class="meta-info"> June 1, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/gynecologic-cancer/news/print/hematology-oncology/{D12C2FC7-58C2-4F83-AC17-A09DD557C565}/Maintenance-pazopanib-extends-DFS-in-women-with-advanced-ovarian-cancer"> Maintenance pazopanib extends DFS in women with advanced ovarian cancer</a></h4> </li> <li class="meta-info"> HemOnc Today, July 25, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/oncolytic-immunotherapy-improved-durable-response-survival-in-metastatic-melanoma"> Oncolytic immunotherapy improved durable response, survival in metastatic melanoma</a></h4> </li> <li class="meta-info"> June 1, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/few-dlbcl-relapses-detected-solely-by-post-treatment-surveillance-scans"> Few DLBCL relapses detected solely by post-treatment surveillance scans</a></h4> </li> <li class="meta-info"> May 31, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/hematologic-malignancies/news/print/hematology-oncology/{7E31DED2-A884-47B8-91B9-9EB5C09D6DE2}/Few-DLBCL-relapses-detected-solely-by-post-treatment-surveillance-scans"> Few DLBCL relapses detected solely by post-treatment surveillance scans</a></h4> </li> <li class="meta-info"> HemOnc Today, June 10, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/investigational-agent-shows-promise-in-refractory-cll"> Investigational agent shows promise in refractory CLL </a></h4> </li> <li class="meta-info"> May 31, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/hematologic-malignancies/news/print/hematology-oncology/{7CB24AF8-B3C9-4E98-B597-4E8B56FD1549}/Investigational-agent-shows-promise-in-refractory-CLL"> Investigational agent shows promise in refractory CLL </a></h4> </li> <li class="meta-info"> HemOnc Today, July 25, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/postsurgical-surveillance-sufficient-for-men-with-stage-i-seminoma"> Postsurgical surveillance sufficient for men with stage I seminoma </a></h4> </li> <li class="meta-info"> May 31, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/genitourinary-cancer/news/print/hematology-oncology/{995EABE4-3822-4853-841C-9BA69882246B}/Postsurgical-surveillance-sufficient-for-men-with-stage-I-seminoma"> Postsurgical surveillance sufficient for men with stage I seminoma </a></h4> </li> <li class="meta-info"> HemOnc Today, June 10, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/ipilimumab-plus-nivolumab-induced-long-lasting-tumor-shrinkage-in-advanced-melanoma"> Ipilimumab plus nivolumab induced long-lasting tumor shrinkage in advanced melanoma</a></h4> </li> <li class="meta-info"> May 31, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/melanoma-skin-cancer/news/print/hematology-oncology/{F37F74DA-15D2-4215-9DA0-29D71760693D}/Ipilimumab-plus-nivolumab-induced-long-lasting-tumor-shrinkage-in-advanced-melanoma"> Ipilimumab plus nivolumab induced long-lasting tumor shrinkage in advanced melanoma</a></h4> </li> <li class="meta-info"> HemOnc Today, June 10, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/pd-l1-targeted-antibody-induced-tumor-shrinkage-in-several-cancer-types"> PD-L1 targeted antibody induced tumor shrinkage in several cancer types </a></h4> </li> <li class="meta-info"> May 31, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/genitourinary-cancer/news/print/hematology-oncology/{B281A530-36B8-41B7-A080-BF9C04F23012}/PD-L1-targeted-antibody-induced-tumor-shrinkage-in-several-cancer-types"> PD-L1 targeted antibody induced tumor shrinkage in several cancer types </a></h4> </li> <li class="meta-info"> HemOnc Today, June 25, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/standard-dose-radiation-superior-to-high-dose-in-stage-iii-nsclc"> Standard-dose radiation superior to high dose in stage III NSCLC</a></h4> </li> <li class="meta-info"> May 31, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/lung-cancer/news/print/hematology-oncology/{38EBFD4F-9BA6-417C-91A2-BD820CBB0FAC}/Standard-dose-radiation-superior-to-high-dose-in-stage-III-NSCLC"> Standard-dose radiation superior to high dose in stage III NSCLC</a></h4> </li> <li class="meta-info"> HemOnc Today, June 10, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/highlights-from-asco-2013/cardiovascular-fitness-in-middle-aged-men-reduced-cancer-risk-mortality"> Cardiovascular fitness in middle-aged men reduced cancer risk, mortality</a></h4> </li> <li class="meta-info"> May 31, 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/gastrointestinal-cancer/news/print/endocrine-today/{ED28A4FB-2525-47B1-9559-A88D0A2EE30F}/Cardiovascular-fitness-in-middle-aged-men-reduced-cancer-risk-mortality"> Cardiovascular fitness in middle-aged men reduced cancer risk, mortality</a></h4> </li> <li class="meta-info"> Endocrine Today, June 2013</li> </ul> <ul class="content-headline-list"> <li class="kicker"> <span class="dept">Meeting News Coverage</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/gastrointestinal-cancer/news/print/hematology-oncology/{F3A42A8A-183F-4C48-AB98-F2F5D6419489}/Cardiovascular-fitness-in-middle-aged-men-reduced-cancer-risk-mortality"> Cardiovascular fitness in middle-aged men reduced cancer risk, mortality</a></h4> </li> <li class="meta-info"> HemOnc Today, June 25, 2013</li> </ul> </div> <a href="#" class="jump-link-alt left" id="slick-slidetoggle">See All 禄</a>   <div class="recent-meetings"> <h3>Recent Meetings</h3> <ul> <li><a href="/web/20130901061442/http://www.healio.com/hematology-oncology/meetings/meeting-news-coverage?setid={328E58E1-E201-4F1D-8237-6F9B285B309E}">2013 ASCO Annual Meeting</a></li> <li class="meeting-meta">Chicago, IL</li> </ul> <ul> <li><a href="/web/20130901061442/http://www.healio.com/hematology-oncology/meetings/meeting-news-coverage?setid={700DE576-BA0E-4598-9BD5-A929D73C2CCA}">WIN 2013 Symposium</a></li> <li class="meeting-meta">Paris, France</li> </ul> <ul> <li><a href="/web/20130901061442/http://www.healio.com/hematology-oncology/meetings/meeting-news-coverage?setid={E5CBFDF0-5856-42F1-99CE-EF2C5DE8EDE1}">HemOnc Today Melanoma and Cutaneous Malignancies symposium</a></li> <li class="meeting-meta">New York, NY</li> </ul> <ul> <li><a href="/web/20130901061442/http://www.healio.com/hematology-oncology/meetings/meeting-news-coverage?setid={E44C6CB8-26C5-45D6-97F3-C80DCE81499A}">2012 ASCO Annual Meeting</a></li> <li class="meeting-meta"></li> </ul> <ul> <li><a href="/web/20130901061442/http://www.healio.com/hematology-oncology/meetings/meeting-news-coverage?setid={F42B5058-DE80-452A-9B53-144A1C8920A5}">2012 ASH Annual Meeting</a></li> <li class="meeting-meta">Atlanta</li> </ul> <ul> <li><a href="/web/20130901061442/http://www.healio.com/hematology-oncology/meetings/meeting-news-coverage?setid={66E36258-17CD-4B42-98A0-A38352F31CA7}">Gastrointestinal Cancers Symposium</a></li> <li class="meeting-meta">San Francisco</li> </ul> <ul> <li><a href="/web/20130901061442/http://www.healio.com/hematology-oncology/meetings/meeting-news-coverage?setid={2503BFD7-1FA6-426C-9ADC-779ACBCB7AFC}">San Antonio Breast Cancer Symposium</a></li> <li class="meeting-meta"></li> </ul> <ul> <li><a href="/web/20130901061442/http://www.healio.com/hematology-oncology/meetings/meeting-news-coverage?setid={F8978212-A6C8-455F-AFC4-4881E4637AD5}">2012 ASCO Breast Cancer Symposium</a></li> <li class="meeting-meta">San Francisco</li> </ul> <ul> <li><a href="/web/20130901061442/http://www.healio.com/hematology-oncology/meetings/meeting-news-coverage?setid={D078A3CB-9243-46F4-9006-22D56F0EA1BE}">2012 Digestive Disease Week Annual Meeting</a></li> <li class="meeting-meta"></li> </ul> <ul> <li><a href="/web/20130901061442/http://www.healio.com/hematology-oncology/meetings/meeting-news-coverage?setid={C93EADD6-A921-4016-83E0-195F899BE8FF}">HemOnc Today Melanoma and Cutaneous Malignancies</a></li> <li class="meeting-meta"></li> </ul> </div>   <div id="layout_0_phmaincontent_1_pagination_divPagination" class="pagination"> <ul> <li> <a class="current page" href="/web/20130901061442/http://www.healio.com/hematology-oncology/meetings/meeting-news-coverage?Filter=&startItem=0"> 1 </a> </li> <li> <a class="page" href="/web/20130901061442/http://www.healio.com/hematology-oncology/meetings/meeting-news-coverage?Filter=&startItem=10"> 2 </a> </li> <li> <a class="page" href="/web/20130901061442/http://www.healio.com/hematology-oncology/meetings/meeting-news-coverage?Filter=&startItem=20"> 3 </a> </li> <li> <a class="page" href="/web/20130901061442/http://www.healio.com/hematology-oncology/meetings/meeting-news-coverage?Filter=&startItem=30"> 4 </a> </li> </ul> </div>  </div>    <div id="sidebar">   <div id="featured-most-popular" class="featured-tabs"> <div class="featured-tab-group"> <ul class="tabs"> <li><a class="active" href="#featured">Featured</a> </li> <li><a href="#mostpopular">Most Popular</a> </li> </ul>  <div class="panes">  <div id="featured"> <ul class=""> <li class="kicker"> <span class="dept">In the Journals</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/hematology/news/online/{68EFAAFC-FD05-4925-BA26-667B10E51F70}/D-dimer-levels-may-predict-postoperative-VTE"> D-dimer levels may predict postoperative VTE</a></h4> </li> <li class="meta-info"> August 30, 2013</li> </ul> <ul class=""> <li class="kicker"> </li> <li> <h4> <a href="https://web.archive.org/web/20130901061442/http://video.healio.com/video/Genomic-landscape-of-cancer"> Genomic testing could alter cancer management reimbursement</a></h4> </li> <li class="meta-info"> July 25, 2013</li> </ul> <ul class=""> <li class="kicker"> <span class="books-flag">Books</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/books/gastroenterology/{D0336EFD-9DC4-4709-A7AE-6A2BF1EA52B4}/Clinical-Challenges-and-Complications-of-IBD"> Clinical Challenges and Complications of IBD</a></h4> </li> <li class="meta-info"> Miguel D Regueiro, MD; Jason Swoger, MD MPH<br/>2012; ISBN 1-55642-980-0</li> </ul> </div>  <div id="mostpopular"> <ul class=""> <li class="kicker"> <span class="dept">In the Journals</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/prostate-cancer/news/online/{297D9C8C-0D64-4667-AF3D-924D408D5AAA}/Finasteride-linked-to-reduced-prostate-cancer-risk-no-effect-on-OS"> Finasteride linked to reduced prostate cancer risk, no effect on OS</a></h4> </li> <li class="meta-info"> August 16, 2013</li> </ul> <ul class=""> <li class="kicker"> <span class="dept">In the Journals</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/dermatology/cutaneous-oncology/news/online/{B808D7A8-21BC-4098-87C0-31AE9ECA02B2}/Surgery-and-cetuximab-most-effectively-treated-very-high-risk-CSCC"> Surgery and cetuximab most effectively treated very high-risk CSCC</a></h4> </li> <li class="meta-info"> August 30, 2013</li> </ul> <ul class=""> <li class="kicker"> <span class="dept">In the Journals</span> <span class="perspective-flag">Perspective</span> </li> <li> <h4> <a href="/web/20130901061442/http://www.healio.com/hematology-oncology/hematology/news/online/{68EFAAFC-FD05-4925-BA26-667B10E51F70}/D-dimer-levels-may-predict-postoperative-VTE"> D-dimer levels may predict postoperative VTE</a></h4> </li> <li class="meta-info"> August 30, 2013</li> </ul> </div> </div> </div> </div>  <div id="personalized-content"> <div class="sidebar-box" id="personalized"> <h4 class="pc-bar"> Personalize your page!</h4> <p> Register for Healio to get content tailored to your specialty and areas of interest. It鈥檚 FREE and only takes one minute. <a id="layout_0_ctl00_sidebarabovead_1_RegisterNow" rel="nofollow" href="/web/20130901061442/http://www.healio.com/footer/account-information/login">Register now!</a></p> </div> </div>  <div class="sidebar-ad-box">  <div id="div-gpt-ad-1369169134306-3"> <script type="text/javascript"> googletag.cmd.push(function() { googletag.display('div-gpt-ad-1369169134306-3'); }); </script> </div> </div>    <div id="text-ad" class="sidebar-box"> <h5> Advertisement </h5> <ul> <li class="first"><strong>Resources from Industry</strong> </li> <li id="layout_0_ctl00_Ad1">  <div id="div-gpt-ad-1369169134306-6"> <script type="text/javascript"> googletag.cmd.push(function() { googletag.display('div-gpt-ad-1369169134306-6'); }); </script> </div> </li><li id="layout_0_ctl00_Ad2" class="last">  <div id="div-gpt-ad-1369169134306-7"> <script type="text/javascript"> googletag.cmd.push(function() { googletag.display('div-gpt-ad-1369169134306-7'); }); </script> </div> </li> </ul> </div>  <div class="sidebar-ad-box">  <div id="div-gpt-ad-1369169134306-1"> <script type="text/javascript"> googletag.cmd.push(function() { googletag.display('div-gpt-ad-1369169134306-1'); }); </script> </div> </div> <div class="sidebar-ad-box">  <div id="div-gpt-ad-1369169134306-2"> <script type="text/javascript"> googletag.cmd.push(function() { googletag.display('div-gpt-ad-1369169134306-2'); }); </script> </div> </div> </div>   </div>  </div>   <div id="footer"> <div class="btm-leaderboard">  <div id="div-gpt-ad-1369169134306-0"> <script type="text/javascript"> googletag.cmd.push(function() { googletag.display('div-gpt-ad-1369169134306-0'); }); </script> </div> </div> <div id="footer-link-group"> <div class="footer-link-group-1"> <h5> Account Information</h5> <ul class="col1"> <li class=""><a href="/web/20130901061442/http://www.healio.com/footer/account-information/create-new-user?ReturnUrl=%2fhematology-oncology%2fmeetings%2fmeeting-news-coverage" target="_self"> Create New User</a></li> <li class=""><a href="/web/20130901061442/http://www.healio.com/footer/account-information/expired-promotion" target="_self"> </a></li> <li class=""><a href="/web/20130901061442/http://www.healio.com/subscribe" target="_self"> Subscribe Or Buy</a></li> <li class=""><a href="/web/20130901061442/http://www.healio.com/footer/account-information/login?ReturnUrl=%2fhematology-oncology%2fmeetings%2fmeeting-news-coverage" target="_self" rel="nofollow"> Login</a></li> </ul> <ul class="col2"> <li class=""><a href="/web/20130901061442/http://www.healio.com/footer/account-information/update-publication-mailing-address" target="_self"> Update Publication Mailing Address</a></li> <li class=""><a href="/web/20130901061442/http://www.healio.com/footer/account-information/help" target="_self"> Help</a></li> </ul> </div> <div class="footer-link-group-2"> <h5> Healio.com</h5> <ul class="col1"> <li class=""><a href="/web/20130901061442/http://www.healio.com/footer/healio-dot-com/about-healio" target="_self"> About Healio</a></li> <li class=""><a href="/web/20130901061442/http://www.healio.com/footer/healio-dot-com/publications" target="_self"> Publications</a></li> <li class=""><a href="/web/20130901061442/http://www.healio.com/footer/healio-dot-com/editorial-board" target="_self"> Editorial Board</a></li> <li class=""><a href="/web/20130901061442/http://www.healio.com/footer/healio-dot-com/contact-the-news-desk" target="_self"> Contact the News Desk</a></li> </ul> <ul class="col2"> <li class=""><a href="/web/20130901061442/http://www.healio.com/footer/healio-dot-com/contact-us" target="_self"> Contact Us</a></li> <li class=""><a href="/web/20130901061442/http://www.healio.com/footer/healio-dot-com/about-the-wyanoke-group" target="_self"> About the Wyanoke Group</a></li> <li class=""><a href="/web/20130901061442/http://www.healio.com/footer/healio-dot-com/advertising-information" target="_self"> Advertising Information</a></li> <li class=""><a href="/web/20130901061442/http://www.healio.com/footer/healio-dot-com/reprints" target="_self"> Reprints</a></li> </ul> <ul class="col3"> <li class=""><a href="/web/20130901061442/http://www.healio.com/footer/healio-dot-com/sitemap" target="_self"> Sitemap</a></li> </ul> </div> <div class="footer-link-group-3"> <h5> Legal</h5> <ul class="col1"> <li class=""><a href="/web/20130901061442/http://www.healio.com/footer/legal/medical-disclaimer" target="_self"> Medical Disclaimer</a></li> <li class=""><a href="/web/20130901061442/http://www.healio.com/footer/legal/privacy-policy" target="_self"> Privacy Policy</a></li> <li class=""><a href="/web/20130901061442/http://www.healio.com/footer/legal/editorial-policy-and-philosophy" target="_self"> Editorial Policy and Philosophy</a></li> <li class=""><a href="/web/20130901061442/http://www.healio.com/footer/legal/terms-and-conditions" target="_self"> Terms and Conditions</a></li> </ul> <ul class="col2"> <li class=""><a href="/web/20130901061442/http://www.healio.com/footer/legal/permissions" target="_self"> Permissions</a></li> </ul> </div> <div class="footer-link-group-4"> <h5> Connect with Healio</h5> <ul class=""> <li class="twitter"><a href="https://web.archive.org/web/20130901061442/https://twitter.com/#!/GoHealio" target="_blank"> Twitter</a></li> <li class="fb"><a href="https://web.archive.org/web/20130901061442/http://www.facebook.com/pages/Healio/304788272902541" target="_blank"> Facebook</a></li> <li class="rss"><a href="/web/20130901061442/http://www.healio.com/rss" target="_self"> RSS Feeds</a></li> </ul> </div> </div> <p class="copyright">©2013 All Rights Reserved.</p> <a href="https://web.archive.org/web/20130901061442/http://www.healio.com/pearlescentcabinet.aspx"><span style="display: none;">position</span></a> </div>  </form> <script type="text/javascript" src="https://web.archive.org/web/20130901061442js_/http://c341136.r36.cf1.rackcdn.com/healiojs-min20130827.js"></script> <script type="text/javascript"> var _gaq = _gaq || []; var pluginUrl = 'https://web.archive.org/web/20130901061442/http://www.google-analytics.com/plugins/ga/inpage_linkid.js'; _gaq.push(['_require', 'inpage_linkid', pluginUrl]); _gaq.push(['_setAccount', 'UA-671605-73']); _gaq.push(['_trackPageview']); _gaq.push(['_setCustomVar',1,'Profession','',1]); _gaq.push(['_setCustomVar',2,'Specialty','|',1]); _gaq.push(['_setCustomVar',3,'Verification Status','False',1]); _gaq.push(['_setCustomVar',5,'UserID','',1]); _gaq.push(['_setCustomVar',4,'Section','Hematology/Oncology||Hematology Meetings & Oncology Meetings',3]); (function() { var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true; ga.src = ('https:' == document.location.protocol ? 'https://web.archive.org/web/20130901061442/https://ssl' : 'https://web.archive.org/web/20130901061442/http://www') + '.google-analytics.com/ga.js'; var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s); })(); function trackClick(link,category,action, label, isExternal) { if(isExternal == null) isExternal = 0; if(label == null) label = link; if(isExternal == 0){ label = 'Internal - ' + label; } else{ label = 'External - ' + label; } _gaq.push(['_setAccount', 'UA-671605-73']); _gaq.push(['_trackEvent', category, action, label]); if(isExternal == 0) { setTimeout('window.location=\'' + link + '\'', 100); } return true; } function gInitLightbox() { var anchors = document.getElementsByTagName('a'); var imgTypes = new Array("jpg", "gif", "png"); var tgtTypes = new Array("blank", "new"); var ignoreIDs = new Array("pdf"); var ignoreClass = new Array("nlb"); var fileExt; var hostname = window.location.hostname; var arrhostname = hostname.split("."); var domain = arrhostname[(arrhostname.length -2)] + "." + arrhostname[(arrhostname.length -1)] for (var x = 0; x < anchors.length; x++) { var h = anchors[x].href.toString(); var t = anchors[x].target.toLowerCase().replace("_", ""); var i = anchors[x].id.toLowerCase(); var c = anchors[x].className.toLowerCase(); var hostsubstridx = h.indexOf(domain+"/"); if(hostsubstridx > -1){ hostsubstridx += (domain+"/").length; h = h.substr(hostsubstridx,(h.length - hostsubstridx)); } var tmp = h.split("."); fileExt = tmp[(tmp.length - 1)]; if(ignoreIDs.indexOf(i) == -1 && ignoreClass.indexOf(c) == -1){ if (imgTypes.indexOf(fileExt) > -1 || (h.indexOf("~/media/") > -1 && fileExt == 'ashx')) { anchors[x].rel = 'lightbox'; anchors[x].target = ''; } } } $j('a[rel*=lightbox]').lightBox({ imageLoading:'/presentation/images/lightbox-ico-loading.gif', imageBtnClose:'/presentation/images/lightbox-btn-close.gif', imageBtnPrev:'/presentation/images/lightbox-btn-prev.gif', imageBtnNext:'/presentation/images/lightbox-btn-next.gif', imageBlank:'/presentation/images/lightbox-blank.gif' }); } $j(document).ready(function() { gInitLightbox(); $j("ul#subspecialty-menu-b li a[href$='/cardiology/acute-coronary-syndrome-resource-center'][class$='resource']").click(function () { _gaq.push(['_setAccount', 'UA-671605-73']); _gaq.push(['_trackEvent', 'AstraZeneca Resource Center', 'Access Link', 'Subspecialty Menu B']); }); }); </script>  <script type="text/javascript"> __compete_code = '16e6ba5f18f1b237ad91753264c4dc2c'; /* Set control variables below this line. */ </script> <script type="text/javascript" src="//web.archive.org/web/20130901061442js_/http://c.compete.com/bootstrap/s/16e6ba5f18f1b237ad91753264c4dc2c/healio-com/bootstrap.js"></script> <noscript> <img width="1" height="1" src="https://web.archive.org/web/20130901061442im_/https://ssl-healio-com-16e6ba.c-col.com/"/> </noscript>  <span id="dbg"></span> <script type="text/javascript" language="javascript" src="https://web.archive.org/web/20130901061442js_/http://50f7680153f6cba9e65f-a4a4842ad50f9edc1b98e79695b0495a.r26.cf1.rackcdn.com/dfpexpand.js"> </script> <input name="api_info_target" type="hidden" id="api_info_target"/> <div id="dmdjscript"> <script src="//web.archive.org/web/20130901061442js_/http://ajax.googleapis.com/ajax/libs/jquery/1.8.0/jquery.min.js" type="text/javascript"></script> <script type="text/javascript">window.A8AJQ = jQuery.noConflict();</script> <script src="https://web.archive.org/web/20130901061442js_/http://50f7680153f6cba9e65f-a4a4842ad50f9edc1b98e79695b0495a.r26.cf1.rackcdn.com/dmd_api.js" type="text/javascript"></script> <script language="javascript" type="text/javascript"> window.A8AJQ(document).ready(function () { window._A8A.check_for_cookie(true); }); </script> </div> <script type="text/javascript" language="javascript" src="https://web.archive.org/web/20130901061442js_/http://50f7680153f6cba9e65f-a4a4842ad50f9edc1b98e79695b0495a.r26.cf1.rackcdn.com/moduleTracking.js"> </script> <script type="text/javascript"> if (!NREUMQ.f) {NREUMQ.f=function() {NREUMQ.push(["load",new Date().getTime()]);var e=document.createElement("script"); e.type="text/javascript"; e.src=(("http:"===document.location.protocol)?"http:":"https:") + "//" + "js-agent.newrelic.com/nr-100.js"; document.body.appendChild(e);if(NREUMQ.a)NREUMQ.a();};NREUMQ.a=window.onload;window.onload=NREUMQ.f;};NREUMQ.push(["nrfj","beacon-2.newrelic.com","d03feeacda","1851818","YAEAbEZTCkZZAExeWVlLI2tkHRRHXRBdWUJWEAtXWh0IVEEMTUNFGAwHWVhbCxpVBlxeVVYIQlVVRhZcQENPUlQXCANBW0cQG1kQSE8=",0,4336,new Date().getTime(),"B08337710FED096F","","","",""]);</script></body> </html>

CINXE.COM

Meeting News Coverage